8-71844019-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005098.4(MSC):āc.160G>Cā(p.Gly54Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000545 in 1,578,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005098.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSC | NM_005098.4 | c.160G>C | p.Gly54Arg | missense_variant | 1/2 | ENST00000325509.5 | NP_005089.2 | |
MSC-AS1 | NR_033652.1 | n.583-210C>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSC | ENST00000325509.5 | c.160G>C | p.Gly54Arg | missense_variant | 1/2 | 1 | NM_005098.4 | ENSP00000321445.4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000483 AC: 9AN: 186492Hom.: 0 AF XY: 0.0000580 AC XY: 6AN XY: 103406
GnomAD4 exome AF: 0.0000554 AC: 79AN: 1426268Hom.: 0 Cov.: 31 AF XY: 0.0000594 AC XY: 42AN XY: 707000
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2024 | The c.160G>C (p.G54R) alteration is located in exon 1 (coding exon 1) of the MSC gene. This alteration results from a G to C substitution at nucleotide position 160, causing the glycine (G) at amino acid position 54 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at